Use of Rosuvastatin to Achieve Lipid Targets in African American Subjects With Cerebrovascular Disease

Trial Profile

Use of Rosuvastatin to Achieve Lipid Targets in African American Subjects With Cerebrovascular Disease

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 18 Nov 2013

At a glance

  • Drugs Rosuvastatin (Primary)
  • Indications Cerebrovascular disorders; Hypercholesterolaemia; Stroke; Transient ischaemic attacks
  • Focus Therapeutic Use
  • Most Recent Events

    • 18 Nov 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top